Revolve Wealth Partners LLC Invests $784,000 in Cardinal Health, Inc. $CAH

Revolve Wealth Partners LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,300 shares of the company’s stock, valued at approximately $784,000.

Other institutional investors have also added to or reduced their stakes in the company. Integrated Wealth Concepts LLC grew its position in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in shares of Cardinal Health in the second quarter valued at approximately $1,935,000. Cerity Partners LLC increased its stake in shares of Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after buying an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC raised its holdings in Cardinal Health by 34.4% in the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after buying an additional 2,646 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

CAH opened at $236.77 on Tuesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $244.87. The company’s 50-day moving average is $227.47 and its 200 day moving average is $216.44. The firm has a market capitalization of $55.45 billion, a PE ratio of 36.20, a P/E/G ratio of 1.16 and a beta of 0.49.

Wall Street Analyst Weigh In

CAH has been the topic of several recent research reports. Morgan Stanley lifted their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Citigroup raised their price target on shares of Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Wells Fargo & Company cut their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Mizuho raised their target price on Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Finally, Bank of America upped their price target on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $251.73.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.